Orbit Discovery Announces $7.6 Million Funding to Accelerate Growth in Peptide Discovery Business

22 Jul, 2021

Orbit Discovery Announces $7.6 Million Funding to Accelerate Growth in Peptide Discovery Business
Photo by Ilya Pavlov on Unsplash

– Orbit Discovery has raised $7.6m in funding.
– The financing was led by Oxford Sciences Innovation with participation from Borealis Ventures, Perivoli Innovations, and other institutional and individual investors, including Kapil Dev Joory.
– Proceeds from the financing will be used to accelerate Orbit’s growth trajectory as a leading provider of peptide discovery services to the biotechnology and pharmaceutical industry.
– Orbit’s novel bead-based and microfluidic technology platform enables the screening of peptide libraries for target binding and subsequent activity in cell-based functional assays.
– This makes the platform ideal for identifying active peptides against both soluble proteins and membrane bound targets such as GPCRs.
– Until now, researchers have struggled to unite high throughput affinity screens with functional screens utilising peptide libraries of very high chemical diversity.

Biotechnology Health Care Manufacturing Western Europe
Crunchbase icon

Content report

The following text will be sent to our editors: